The World's First Clinical Randomized Trial of Atrial Natriuretic Peptide for Preventing Cancer Recurrence Following Lung Cancer Surgery

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/2050-6511-16-s1-a72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Atrial Natriuretic Peptide: A Suspected Biomarker of Breast Cancer

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2017English

Serum Carcinoembryonic Antigen Trends for Diagnosing Colorectal Cancer Recurrence in the FACS Randomized Clinical Trial

British Journal of Surgery
Surgery
2018English

High-Intensity Training Following Lung Cancer Surgery: A Randomised Controlled Trial

Thorax
PulmonaryRespiratory Medicine
2014English

Postoperative Empyema Following Lung Cancer Surgery

Oncotarget
Oncology
2018English

Brain Natriuretic Peptide and Risk of Atrial Fibrillation After Thoracic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Correction for Nojiri Et Al., Atrial Natriuretic Peptide Prevents Cancer Metastasis Through Vascular Endothelial Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Factors Affecting Chronic Cough Following Lung Cancer Surgery

Respirology
PulmonaryRespiratory Medicine
2019English

Stability of Plasma Atrial Natriuretic Peptide

Circulation
Cardiovascular MedicinePhysiologyCardiology
1993English

P1.16-61 Intermittent Chest Tube Clamping Shortens Chest Tube Duration After Lung Cancer Surgery: An Interim Analysis of Randomized Clinical Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy